2009
2008
2007
2006
2005
2004
2003
2001
1999
bullet

2009:

bullet

Successful US FDA inspection of all 5 clinical trial sites and Ahmedabad Facility

bullet

Successful inspection of Ahmedabad and Mumbai facilities by OGYI - Hungarian Medical Regulatory Authority

bullet

Successful inspection of Poland Facilities by Austrian Regulatory Authority
 

bullet

2008:

bullet

ANVISA approval received for new Ahmedabad facility

bullet

Approval by CAP (College of American Pathologists, USA) for the new facility

bullet

Lambda built a world-class infrastructure spread over 250,000 sq. ft. at Ahmedabad, India. All the services at Ahmedabad headquarters have been operational from this new premises “Lambda House” since the beginning of year 2008 with 264 beds

bullet

Entry into the pharmacovigilance segment by acquisition of PV solutions Ltd, UK

bullet

Development of an ECG core lab and the capability to undertake QT-QTc studies

bullet

Successful completion of an osteoarthritis phase III study on 1886 subjects from 43 sites within 7 months for EMEA submission

bullet

Lambda conducted many studies on unconventional population subjects like postmenopausal females, surgically sterile females, geriatrics, renal-impaired and hepatic impaired subjects

bullet

Lambda developed bioanalytical methods on many new molecules like bisphosphonates (alendronate, ibandronate and risedronate), Vitamin D, hormones, Ezetimibe etc.
 

bullet

2007:

bullet

First successful USFDA inspection at Mumbai

bullet

Acquisition of CBK-MPR in Poland to gain operational presence in Europe

bullet

DCGI, India grants approval to the Ahmedabad facility
 

bullet

2006:
 
bullet

As a part of business expansion, bed capacity increased by 60 beds to 120 beds at Ahmedabad

bullet

Screening facility at Mehsana and Patan in Gujarat

bullet

2005:
 
bullet

Our Clinical Lab, the fifth in country to get accredited by College of American Pathologists

bullet

First successful USFDA inspection

bullet

Initiated Scientific Data Management System (SDMS) for Bioanalytical Laboratory
 

bullet

2004:
 
bullet

Our facility got satisfactorily inspected by the regulatory bodies like ANVISA, WHO and AFSSAPS (France)
 

bullet

2003:
 
bullet

As a part of business expansion, started phase II and III clinical trials.

bullet

Expanded our operations to Mumbai
 

bullet

2001:
 
bullet

As an add-on to our infrastructure, started our own Clinical Laboratory with most sophisticated instruments
 

bullet

1999:
 
bullet

Started our operations at Ahmedabad with a team of 6 members and an infrastructure of 24 beds, 1 LC/MS and 6 HPLCs

Lambda Therapeutic Research Ltd.
A CRO for Clinical Research, Clinical Trials, Medical Writing, Bioanalytical, Bioequivalence and Pharmacovigilance services.
India (Ahmedabad - Mumbai), Poland (Warsaw), USA